Abstract
Chemoinfectomics (chemical infectomics) is the study of small exogenous molecules that are highly specified to define molecular targets (e.g., genes, proteins, glycans, and lipids) or infectomic signatures, to enable functional analysis of microbes and their hosts, and to uncover new antimicrobial drug leads. It requires multidisciplinary expertise in chemical omics (chemogenomics, chemoproteomics, chemoglycomics and chemolipidomics), infectious diseases, and computational sciences (bioinformatics, cheminformatics, large scale statistics and machine learning methods). Chemoinfectomics will overcome the major limitation of the conventional paradigm of managing infectious diseases, which has mainly targeted on microorganisms with low selectivity. The development of drug resistance to both pathogenic and nonpathogenic microbes has been one of the most serious disadvantages of the traditional microbe-directed drug targeting strategies. Therefore, a new chemoinfectomics-based drug discovery paradigm has emerged, focusing on identifying and targeting host factors essential for microbial interactions and pathogenesis. Innovative strategies combining chemoinfectomics, computational biology, and conventional targeting of microbial virulence factors have the potential to greatly augment the protective host factors and to specifically and efficiently eliminate the invading pathogen.
Keywords: Activity-based profiling (ABP), chemogenomics, chemoglycomics, chemoinfectiomics, chemolipidomics, chemoproteomics, infectomes, miroarrays, multidrug resistance (MDR).
Anti-Infective Agents
Title:Chemoinfectomics in Drug Design and Development
Volume: 11 Issue: 2
Author(s): Sheng-He Huang, Hongwei Xia, Feng Chi, Naila K. Khalaf and Ambrose Jong
Affiliation:
Keywords: Activity-based profiling (ABP), chemogenomics, chemoglycomics, chemoinfectiomics, chemolipidomics, chemoproteomics, infectomes, miroarrays, multidrug resistance (MDR).
Abstract: Chemoinfectomics (chemical infectomics) is the study of small exogenous molecules that are highly specified to define molecular targets (e.g., genes, proteins, glycans, and lipids) or infectomic signatures, to enable functional analysis of microbes and their hosts, and to uncover new antimicrobial drug leads. It requires multidisciplinary expertise in chemical omics (chemogenomics, chemoproteomics, chemoglycomics and chemolipidomics), infectious diseases, and computational sciences (bioinformatics, cheminformatics, large scale statistics and machine learning methods). Chemoinfectomics will overcome the major limitation of the conventional paradigm of managing infectious diseases, which has mainly targeted on microorganisms with low selectivity. The development of drug resistance to both pathogenic and nonpathogenic microbes has been one of the most serious disadvantages of the traditional microbe-directed drug targeting strategies. Therefore, a new chemoinfectomics-based drug discovery paradigm has emerged, focusing on identifying and targeting host factors essential for microbial interactions and pathogenesis. Innovative strategies combining chemoinfectomics, computational biology, and conventional targeting of microbial virulence factors have the potential to greatly augment the protective host factors and to specifically and efficiently eliminate the invading pathogen.
Export Options
About this article
Cite this article as:
Huang Sheng-He, Xia Hongwei, Chi Feng, Khalaf Naila K. and Jong Ambrose, Chemoinfectomics in Drug Design and Development, Anti-Infective Agents 2013; 11 (2) . https://dx.doi.org/10.2174/2211352511311020003
DOI https://dx.doi.org/10.2174/2211352511311020003 |
Print ISSN 2211-3525 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-3533 |
Call for Papers in Thematic Issues
An Overview of Drugs for Multiple Targets and Variants of SARS-CoV-2 Through Artificial Intelligence, Machine Learning, Deep Learning, and Experimental Analysis
The emergence and rapid evolution of SARS-CoV-2 variants have posed significant challenges in the ongoing fight against the COVID-19 pandemic. The development of effective treatments for multiple viral targets and variants demands innovative approaches, including artificial intelligence (AI), machine learning (ML), and deep learning (DL) techniques. This special issue aims ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Genetically Engineered Stem Cells for Therapeutic Gene Delivery
Current Gene Therapy Novel Antibacterial Agents: An Emergent Need to Win the Battle Against Infections
Mini-Reviews in Medicinal Chemistry Targeting the Chemokine Receptor CXCR3 and Its Ligand CXCL10 in the Central Nervous System: Potential Therapy for Inflammatory Demyelinating Disease?
Current Neurovascular Research Clinical Uses of Melatonin: Evaluation of Human Trials
Current Medicinal Chemistry Colored Representation of Brain Gray Scale MRI Images to Potentially Underscore the Variability and Sensitivity of Images
Current Medical Imaging Management of Tuberculosis in Children and New Treatment Options
Infectious Disorders - Drug Targets Bladder Cancer: A Simple Model Becomes Complex
Current Genomics Fluorinated Molecules as Drugs and Imaging Agents in the CNS
Current Topics in Medicinal Chemistry Nanocarriers Based Anticancer Drugs: Current Scenario and Future Perceptions
Current Drug Targets Laccase Regulators in Anti-fungal Drug Discovery: Dark Lessons from the AIDS-related Pathogen, Cryptococcus
Current Enzyme Inhibition Phosphodiesterase as a New Therapeutic Target for the Treatment of Spinal Cord Injury and Neurodegenerative Diseases
Current Medicinal Chemistry Antiviral Agents in the Prevention and Treatment of Virus-Induced Diabetes
Anti-Infective Agents in Medicinal Chemistry Editorial [Revisiting the Paris Declaration: Pharmacogenomics and Personalized Medicine as Accelerators for Development Aid and Effectiveness]
Current Pharmacogenomics and Personalized Medicine Hypersensitivity Reactions to Quinolones
Current Pharmaceutical Design Entry of Oximes into the Brain: A Review
Current Medicinal Chemistry Capsaicin-Sensitive Nociceptive Innervation of the Dura Mater: Implications for the Pathomechanism of Headache
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Blood-Brain Barrier Transport of Short Proline-Rich Antimicrobial Peptides
Protein & Peptide Letters Myelin Sheaths and Autoimmune Response Induced by Myelin Proteins and Alphaviruses. I. Physicochemical Background
Current Medicinal Chemistry Screening of Natural Lead Molecules Against Putative Molecular Targets of Drug-resistant Cryptococcus spp: An Insight from Computer-aided Molecular Design
Current Topics in Medicinal Chemistry Lassa Virus Genome
Current Genomics